Cellective BioTherapy logo

Cellective BioTherapy

Innovative therapies harnessing B cell-based solutions for cancer, autoimmune diseases, and immunodeficiency.

est. 2015

VS
Fresh Wind Biotechnologies logo

Fresh Wind Biotechnologies

Transforming cancer therapeutics with cutting-edge immunotherapy

2 employees · est. 2020 · Houston, United States

Cellective BioTherapy is the older company (2015 vs 2020).

Side-by-Side Comparison

Cellective BioTherapy Fresh Wind Biotechnologies
Founded
2015 older 2020
Headquarters
Not tracked yet Houston, United States
Employees
Not tracked yet 2
Industry
Biotechnology, Health Care, Information Technology Biotechnology, Health and Wellness
Funding Stage
Angel Series A
Total Funding
$2.50M $10.00M
Funding Rounds
2 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cellular Therapy, Monoclonal Antibody, Cancer Treatment, Autoimmunity, Immunodeficiency, B Cell-based Therapy, Immunomodulation, Diabetes Treatment, Asthma Treatment, Vaccine Development, Innovative Therapy, Immune System Modulation Immunotherapy, Cancer Therapeutics, Cellular Immunotherapies, Precision Oncology, Personalized Cancer Treatment, Genomic Data, Proteomic Data, Data Science, Bioinformatics, Cellular Therapy Technologies, Precision Medicine, Cancer Research, Clinical Development, Startup
Website
cellectivebiotherapy.com freshwindbiotech.com
Cellective BioTherapy logo

About Cellective BioTherapy

Cellective BioTherapy is a biotechnology company that focuses on developing innovative therapies utilizing B cell-based solutions for cancer, autoimmune diseases, and immunodeficiency. Since its establishment in 2015, the company has been dedicated to creating cellular and monoclonal antibody-based...

Fresh Wind Biotechnologies logo

About Fresh Wind Biotechnologies

Fresh Wind Biotechnologies, founded in 2020, is pioneering the biotechnology sector by focusing on cutting-edge immunotherapy solutions aimed at transforming cancer therapeutics. The company's slogan, "Transforming cancer therapeutics with cutting-edge immunotherapy," reflects its mission to enhance...

We will tell you when either one moves

BounceWatch watches Cellective BioTherapy and Fresh Wind Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cellective BioTherapy and Fresh Wind Biotechnolo... — by email.

Frequently Asked Questions

Cellective BioTherapy — Innovative therapies harnessing B cell-based solutions for cancer, autoimmune diseases, and immunodeficiency.. Fresh Wind Biotechnologies — Transforming cancer therapeutics with cutting-edge immunotherapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellective BioTherapy has raised $2.50M while Fresh Wind Biotechnologies has raised $10.00M.
Cellective BioTherapy and Fresh Wind Biotechnologies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellective BioTherapy with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Cellective BioTherapy on 12 Sep 2024, and Fresh Wind Biotechnologies on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes